Weixiang Zhong

970 total citations · 1 hit paper
49 papers, 632 citations indexed

About

Weixiang Zhong is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Weixiang Zhong has authored 49 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Weixiang Zhong's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Weixiang Zhong is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Weixiang Zhong collaborates with scholars based in China, Hong Kong and United States. Weixiang Zhong's co-authors include Weiqin Jiang, Yinjun He, Wenguang He, Guosheng Wu, Xile Zhou, Yongfeng Ding, Hanju Hua, Qinsong Sheng, Yimin Lu and Lu Qi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Neuroscience.

In The Last Decade

Weixiang Zhong

44 papers receiving 625 citations

Hit Papers

Exhausted CD8+T Cells in the Tumor Immune Microenvironmen... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Weixiang Zhong
Elena Miranda United Kingdom
A. Nagano United Kingdom
Genevieve J. Kaunitz United States
Brian Labadie United States
Weixiang Zhong
Citations per year, relative to Weixiang Zhong Weixiang Zhong (= 1×) peers Jianying Zeng

Countries citing papers authored by Weixiang Zhong

Since Specialization
Citations

This map shows the geographic impact of Weixiang Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixiang Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixiang Zhong more than expected).

Fields of papers citing papers by Weixiang Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weixiang Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixiang Zhong. The network helps show where Weixiang Zhong may publish in the future.

Co-authorship network of co-authors of Weixiang Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Weixiang Zhong. A scholar is included among the top collaborators of Weixiang Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixiang Zhong. Weixiang Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Jiaxuan, Kexuan Wang, Qing Wang, et al.. (2025). Hypoxia‐Activated Liposomes Enable Synergistic Photodynamic Therapy for Oral Cancer. Advanced Healthcare Materials. 14(9). e2404395–e2404395. 5 indexed citations
3.
Gao, Ge, Xiaoyang Liu, Yao‐Wen Jiang, et al.. (2025). Homologous targeted neutrophils-liposome system for pyroptosis-enhanced antitumor immunotherapy of triple-negative breast cancer. Materials Today Bio. 32. 101904–101904. 1 indexed citations
4.
He, Yinjun, Xiang Zhang, Wenguang He, et al.. (2025). Optimization of Immunotherapy Strategies Based on Spatiotemporal Heterogeneity of Tumour‐Associated Tissue‐Resident Memory T Cells. Immunology. 175(2). 123–133. 1 indexed citations
5.
6.
Zhang, Xiang, Yinjun He, Wenguang He, et al.. (2024). Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer. Therapeutic Advances in Medical Oncology. 16. 2669771–2669771.
7.
He, Yinjun, Xiang Zhang, Ming Zhu, et al.. (2023). Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer. Journal of Translational Medicine. 21(1). 46–46. 25 indexed citations
8.
Zhong, Weixiang, et al.. (2023). APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis. Pathology & Oncology Research. 29. 1610976–1610976. 4 indexed citations
10.
Cheng, Xiaofei, et al.. (2023). Immunotherapy as a promising treatment strategy for dmmr colorectal cancer with brain metastasis: a case report. Journal of Cancer Metastasis and Treatment. 2 indexed citations
11.
Jiang, Weiqin, Yinjun He, Wenguang He, et al.. (2023). Metastatic sites and lesion numbers cooperated to predict efficacy of PD‐1 inhibitor‐based combination therapy for patients with metastatic colorectal cancer. Cancer Medicine. 12(11). 12482–12494. 1 indexed citations
12.
Jiang, Weiqin, Yinjun He, Wenguang He, et al.. (2021). Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy. Frontiers in Immunology. 11. 622509–622509. 225 indexed citations breakdown →
13.
Shi, Feng, Xiaotian Yu, Wenjie Liang, et al.. (2021). Development of a Deep Learning Model to Assist With Diagnosis of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 762733–762733. 14 indexed citations
14.
Zhong, Weixiang & Nissar A. Darmani. (2021). The HCN Channel Blocker ZD7288 Induces Emesis in the Least Shrew (Cryptotis parva). Frontiers in Pharmacology. 12. 647021–647021. 3 indexed citations
15.
Zhong, Weixiang, et al.. (2020). Role of PI3K/Akt/GSK-3 Pathway in Emesis and Potential New Antiemetics. PubMed. 1(4). 155–159. 2 indexed citations
16.
Zhao, Feng, Sunyi Ye, Weixiang Zhong, et al.. (2020). Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study. Frontiers in Oncology. 9. 1467–1467. 10 indexed citations
17.
Liu, Sha, Lin Z. Li, Mosang Yu, et al.. (2018). Mesh migration into the sigmoid colon after inguinal hernia repair presenting as a colonic polyp: A case report and review of literature. World Journal of Clinical Cases. 6(12). 564–569. 10 indexed citations
18.
Zhong, Weixiang, Seetha Chebolu, & Nissar A. Darmani. (2018). Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva). Neurochemistry International. 122. 106–119. 16 indexed citations
19.
Zhang, Guohong, Weixiang Zhong, Liangli Hong, et al.. (2018). Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget’s Diseases. Journal of Investigative Dermatology. 139(4). 789–795. 28 indexed citations
20.
Zhou, Xinxin, Mosang Yu, Mengli Gu, et al.. (2018). Sigmoid colon translocation of an intrauterine device misdiagnosed as a colonic polyp. Medicine. 97(6). e9840–e9840. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026